Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Agomelatine by Alto Neuroscience for Major Depressive Disorder: Likelihood of Approval
Agomelatine is under clinical development by Alto Neuroscience and currently in Phase II for Major Depressive Disorder. According to GlobalData,...